| GWAS |
- Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy) ( 31835028
)
- Autism spectrum disorder or schizophrenia ( 28540026
)
- Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined) ( 23453885
)
- Bevacizumab-induced composite toxicity (either hypertension or proteinuria) ( 34616010
)
- Bipolar disorder ( 33263727
31043756
34002096
)
- Bipolar I disorder ( 31043756
)
- Chronic kidney disease ( 26420894
)
- Clostridioides difficle infection ( 33841421
)
- Cognitive ability, years of educational attainment or schizophrenia (pleiotropy) ( 31374203
)
- Copper levels ( 26025379
)
- Daytime nap ( 33568662
)
- FEV1 ( 30804560
)
- General risk tolerance (MTAG) ( 30643258
)
- Hallux valgus ( 32131869
)
- Hepatitis B ( 22004137
)
- Laryngeal squamous cell carcinoma ( 25194280
)
- Lung function (FVC) ( 30804560
)
- Metabolite levels ( 23823483
)
- Night sleep phenotypes ( 27126917
)
- Refractive error ( 32231278
)
- Rosacea symptom severity ( 29771307
)
- Schizophrenia ( 30285260
29483656
28991256
25056061
)
- Tenofovir clearance in HIV infection ( 26148204
)
- Thiazide-induced adverse metabolic effects in hypertensive patients ( 23400010
)
- Waist circumference adjusted for BMI (smoking interaction) ( 28443625
)
|
|
